The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy
Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Cheng‐Yuan Peng(China Medical University), Hsueh‐Chou Lai(China Medical University), Chia‐Hsin Lin(China Medical University), Chao‐Hung Hung(Kaohsiung Chang Gung Memorial Hospital), Sheng‐Nan Lu(Chang Gung University), Jing‐Houng Wang(Kaohsiung Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University)
Cited by 46
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|552
Hepatogastroenterology
|Hepatogastroenterology|2012|536